Fundz

Medicus Pharma Appoints Dr Faisal Mehmud as Chief Executive Officer

PUBLIC · MDCXAug 04, 2026
Internal move“Dr Mehmud will continue to serve as chief medical officer of Medicus and co-chairman of Antev”

Position

Chief Medical Officer

Company

Medicus Pharma

Faisal Mehmud
West ConshohockenBiotechnologyHealthcareTherapeutics

Description

Medicus Pharma has announced the appointment of Dr Faisal Mehmud as CEO of its UK subsidiary, Antev Limited. This appointment is effective August 30, 2026.

Who to call at Medicus Pharma, and when

A new leader at Medicus Pharma brings new priorities and often new vendors. The first weeks are when they listen.

  • An alert the day Medicus Pharma raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Medicus Pharma, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Medicus Pharma. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Medicus Pharma

Location

100 KING STREET WEST

West Conshohocken, Pennsylvania, United States

About

Medicus Pharma Ltd. (NASDAQ:MDCX) is a biotech/life sciences company focused on accelerating the clinical development programs of novel and potentially disruptive therapeutic assets. The Company is currently advancing the clinical development program of its novel Doxorubicin containing Microneedle Array (D-MNA) treatment to non-invasively treat basal cell carcinoma of the skin (BCC). Medicus is also developing Teverelix, a next generation GnRH Antagonist as a first in class market product for Acute Urinary Retention (AURr) and high CV risk Prostate Cancer. D-MNA and Teverelix, collectively represent ~$8 billion in potential market opportunity.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Medicus Pharma changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

Raza
Likely contact at this company
••••••••@••••••••

See Raza's verified email →

Create an account to reveal verified emails
Predictive Intelligence
Strategic

ML-powered predictions for Medicus Pharma's next move

Learn about Strategic plan

Medicus Pharma changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.